옵션 체인은 다양한 행사가격과 만기일에 대한 Flywire의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Flywire에 대한 시장 심리를 평가합니다..

Flywire (NASDAQ:FLYW) 주식, 옵션 체인

Flywire

Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary global payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

FLYW

TOST

UPST

2024년 11월 8일 기준, 금융 섹터의 3종목의 주식이 모멘텀을 중요하게 여기는 투자자들에게 실질적인 경고 신호를 보낼 수 있다. 상대 강도 지수(RSI)는 모멘텀 지표로, 주가가 상승하는 날의 강도와 하락하는 날의 강도를 비교한다. 주가 행동과 비교할 때, 주식이 단기적으로 어떻게 수행될 수 있는지를 더 잘 이해할 수 있다. Benzinga Pro에 따르면, 일반적으로 RSI가 70 이상일 때 자산이 과매수 상태로 간주된다.

이번 달에 절벽으로 떨어질 수 있는 상위 3개의 금융주

Flywire Corporation - Voting Common Stock

Flywire Corp

FLYWHEEL ADVANCED TECH by Flywheel Advanced Technology Inc.

Flywheel Advanced Technology Inc

RBC Capital analyst Douglas Miehm maintains Oncolytics Biotech (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ONC#TSX">ONC</a>) with a Outperform and lowers the price target from C$6 to C$5.

Price Target

Analyst Ratings

TSX:ONC

RBC Capital Maintains Outperform on Oncolytics Biotech, Lowers Price Target to C$5

RBC Capital analyst Douglas Miehm maintains Oncolytics Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCY#NASDAQ">ONCY</a>) with a Outperform and lowers the price target from $6 to $5.

ONCY

RBC Capital Maintains Outperform on Oncolytics Biotech, Lowers Price Target to $5

CORRECTION: JP Morgan analyst Ken Goldman maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Neutral and lowers the price target from $154 to $102, rating action updated.

FRPT

CORRECTION: JP Morgan Maintains Neutral on Freshpet, Lowers Price Target to $102 (Rating Action Updated)

WIIM

CAVA

SBUX

SHAK

WING

Shares of restaurant companies are trading lower amid recession worries due to uncertainty regarding tariffs and trade policy. President Trump said there is a "period of transition."

<ul>
<li>Vaccine is intended to stimulate T cell responses against targets across the entire genome of the selected virus, similar to company's lead product candidate TVGN 489, to mitigate the risk posed by mutations.</li>
<li>Approach may provide prophylaxis to viral infections and would be complementary to current treatment under development by Tevogen Bio.</li>
<li>Powered by Tevogen Bio's artificial intelligence initiative, Tevogen.AI.</li>
<li>The company hopes to address public concerns about inoculation during vaccine development. &nbsp;</li>
</ul>
WARREN, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=eXaPzBtzXeAPmkm04z0MeyaMBrgxjzaY6QvFIQAv8oeoROGk6K_0lwevCJECwCCt05roXcccuElwT4UjLEmJ3w==">Tevogen Bio</a> ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>), a clinical-stage specialty immunotherapy biotech company, today announced the filing of a new patent with the U.S. Patent and Trademark Office (USPTO) for its under-development T cell vaccine. Unlike many vaccines that primarily induce a B cell response, Tevogen Bio's design aims to leverage the Company's proprietary Tevogen.AI-powered PredicTcell technology to identify peptides which stimulate a T cell response.
A key differentiator of this vaccine is its ability to target the entire viral genome, much like the Company's lead product candidate, TVGN 489. This strategy helps mitigate the risk posed by mutations that might otherwise evade immune detection when only one protein or segment of the virus is targeted.
The development of this vaccine leverages Tevogen Bio's established technology and will not impact previously announced launch year topline forecasts of $1 billion each for Tevogen Bio Oncology and Specialty Care.

Biotech

General

TVGN

Tevogen Bio Announces The Filing Of A New Patent With The USPTO For Its Under-Development T Cell Vaccine

BABA

BEKE

FUTU

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Shares of Chinese stocks are trading lower amid US tariffs.

RBC Capital analyst Michael Carroll maintains Medical Properties Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) with a Sector Perform and raises the price target from $4 to $5.

RBC Capital Maintains Sector Perform on Medical Properties Trust, Raises Price Target to $5

BKNG

EXPE

NCLH

Shares of travel-related companies are trading lower amid recession risks due to uncertainty regarding tariffs and trade policy. President Trump said there is a "period of transition." Economic uncertainty could weigh on travel demand and consumer sentiment.

RBC Capital analyst Michael Carroll maintains Kilroy Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) with a Sector Perform and lowers the price target from $44 to $39.

RBC Capital Maintains Sector Perform on Kilroy Realty, Lowers Price Target to $39

BBWI

BOOT

BURL

CHWY

CPRI

DECK

VSCO

Shares of retail, apparel, and ecommerce stocks are trading lower amid recession worries due to uncertainty regarding tariffs and trade policy. Additionally, consumer spending is expected to be impacted, which is weighing on the industry.

ADSK

ASAN

CDNS

CYBR

DDOG

FICO

FTNT

GTLB

HUBS

INTU

MSFT

NTNX

OKTA

ORCL

PANW

SHOP

SNOW

SOUN

TEAM

TWLO

Shares of software stocks are trading lower amid recession worries due to uncertainty regarding tariffs and trade policy. President Trump said there is a "period of transition." Economic uncertainty could drive a rotation out of growth sectors.

RBC Capital analyst Michael Carroll maintains Easterly Government Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEA#NYSE">DEA</a>) with a Underperform and lowers the price target from $12 to $11.

RBC Capital Maintains Underperform on Easterly Government Props, Lowers Price Target to $11

B of A Securities analyst Lawson Winder maintains Nexa Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEXA#NYSE">NEXA</a>) with a Underperform and lowers the price target from $8 to $6.5.

NEXA

B of A Securities Maintains Underperform on Nexa Res, Lowers Price Target to $6.5

In the current session, American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) is trading at $12.35, after a 5.26% decrease. Over the past month, the stock decreased by 24.74%, and in the past year, by 11.57%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1741624446_0.png" alt="Past Year Chart" />

<h3>Evaluating American Airlines Group P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
American Airlines Group has a lower P/E than the aggregate P/E of 13.29 of the Passenger Airlines industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1741624447_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

A Look Into American Airlines Group Inc's Price Over Earnings

RBC Capital analyst Ashish Sabadra reiterates FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) with a Sector Perform and maintains $503 price target.

Reiteration

RBC Capital Reiterates Sector Perform on FactSet Research Systems, Maintains $503 Price Target

AMAT

ASML

AVGO

CAMT

ENTG

HIMX

INTC

KLAC

LRCX

MCHP

MKSI

MRVL

MTSI

NVDA

NXPI

QCOM

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TSEM

Shares of semiconductor stocks are trading lower amid recession worries due to uncertainty regarding tariffs and trade policy. President Trump said there is a "period of transition."

Schwab clients were buyers of equities in February; Buying in Information Technology, Consumer Discretionary and Communication Services early in the month preceded a shift away from the ‘Magnificent Seven' weeks later
The Schwab Trading Activity Index&#x2122; (STAX) increased to 51.94 in February, up from its score of 49.45 in January. The only index of its kind, the STAX is a proprietary, behavior-based index that analyzes retail investor stock positions and trading activity from Schwab's millions of client accounts to illuminate what investors were actually doing and how they were positioned in the markets each month.
The reading for the four-week period ending February 28, 2025, ranks "moderate" compared to historic averages.

SCHW

The Schwab Trading Activity Index Increased To 51.94 In February, Up From 49.45 In January

RBC Capital analyst Ken Herbert initiates coverage on Karman Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRMN#NYSE">KRMN</a>) with a Outperform rating and announces Price Target of $35.

Initiation

KRMN

RBC Capital Initiates Coverage On Karman Holdings with Outperform Rating, Announces Price Target of $35

Low-cost investing pioneers continue slashing fees while newer exchange-traded funds quietly reverse the industry&#8217;s decades-long trend toward cheaper investing.
The Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) briefly overtook the State Street managed SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) as the world's largest ETF on Feb. 18, only for SPY to reclaim the top spot within days, <a href="https://www.economist.com/finance-and-economics/2025/02/26/how-cheap-can-investing-get">The Economist reported recently</a>. Both S&amp;P 500 tracking funds now manage over $620 billion in assets, with VOO charging just 0.03% and SPY 0.09% annually.
Don't Miss:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
</ul>
The price war among industry giants runs counter to what&#8217;s happening with newer market entrants. According to Morningstar data cited by The Economist, recently launched ETFs have reduced their fee advantage over mutual funds to just 0.2%, down from 0.7% in 2014.
Most ETFs created in recent years charge 0.5% or higher, bucking the historical downward trend in investment costs.
The pricing divide reflects fundamental differences in investment focus. While established funds typically track broad market indices, newer offerings pursue specialized strategies—environmentally conscious investments, stocks with specific characteristics, or actively managed approaches.
Trending: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Scale economics drive the bifurcation. The largest 15 equity ETFs hold $3.9 trillion, exceeding the combined assets of the next 100 funds. According to the Economist, which cited data from Citigroup, roughly half of American ETFs operate at a loss due to insufficient size to cover operational expenses.
Industry leader Vanguard continues pushing costs lower, reducing fees on 87 funds in February and lowering its average expense ratio from 0.08% to 0.07%. With $10 trillion under management—double its 2018 assets—the company leverages massive scale economies while focusing on straightforward index investments.
The relationship between mainstream funds and specialized offerings creates what The Economist describes as a &#8220;strangely symbiotic&#8221; dynamic. Low-cost core holdings reduce overall portfolio expenses, potentially creating budget space for more expensive specialized investments.
See Also: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
For cost-conscious investors, the widening fee gap presents a clear choice. The traditional ETF value proposition—inexpensive broad market exposure—remains intact among established players, while specialized strategies come with premium pricing.
Average industry fees may plateau not from reaching efficiency limits, but because more investors choose specialized products with inherently higher costs. Those sticking with mainstream index offerings, The Economist said, may still realize &#8220;trillions of dollars in savings&#8221; in coming years.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li>The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a></li>
</ul>

Personal Finance

Investing Just Got More Expensive—Unless You Know Where To Look

Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) has outperformed the market over the past 10 years by 20.52% on an annualized basis producing an average annual return of 31.02%. Currently, Strategy has a market capitalization of $66.00 billion. 
Buying $1000 In MSTR: If an investor had bought $1000 of MSTR stock 10 years ago, it would be worth $15,045.72 today based on a price of $253.55 for MSTR at the time of writing.
<h3>Strategy's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741624208_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSTR

Here's How Much $1000 Invested In Strategy 10 Years Ago Would Be Worth Today

Small Cap

Press Releases

Flywire Corporation (FLYW) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Securities Fraud Investigation Into Flywire Corporation (FLYW) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Flywire to Attend Upcoming Investor Conferences

Legal

Flywire Corporation Investors: Company Investigated by the Portnoy Law Firm

Kirby McInerney LLP Announces Investigation Against Flywire Corporation (FLYW) on Behalf of Investors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Flywire Corporation - FLYW

Securities Fraud Investigation Into Flywire Corporation (FLYW) Continues – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

FLYWIRE ALERT: Bragar Eagel & Squire, P.C. is Investigating Flywire Corporation on Behalf of Flywire Stockholders and Encourages Investors to Contact the Firm

Securities Fraud Investigation Into Flywire Corporation (FLYW) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Financing

Flywire and Ascensus Deliver over $2 Billion in 529 College Saving Plan Payments as Demand for Education Affordability Increases

Comments

Flywire

Flywire (FLYW) 옵션

Flywire (NASDAQ:FLYW) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌